High-dose radiotherapy with or without androgen-deprivation therapy for intermediate-risk prostate cancer: Cancer control and toxicity

被引：0
|
作者：
Edelman, S.
Rossi, P. J.
Cooper, S.
Jani, A. B.
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Atlanta VA Med Ctr, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.67
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
67
引用
收藏
页数：1
相关论文
共 50 条
  • [1] High-Dose Radiotherapy With or Without Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer: Cancer Control and Toxicity Outcomes
    Edelman, Scott
    Liauw, Stanley L.
    Rossi, Peter J.
    Cooper, Sherrie
    Jani, Ashesh B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (05): : 1473 - 1479
  • [2] Survival outcomes of radiotherapy with or without androgen-deprivation therapy for patients with intermediate-risk prostate cancer using the National Cancer Data Base
    Amini, Arya
    Rusthoven, Chad G.
    Jones, Bernard L.
    Armstrong, Hirotatsu
    Raben, David
    Kavanagh, Brian D.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (04) : 165.e1 - 165.e9
  • [3] Significance of androgen-deprivation therapy for intermediate- and high-risk prostate cancer treated with high-dose radiotherapy: A literature review
    Aizawa, Rihito
    Ishikawa, Hitoshi
    Kato, Manabu
    Shimizu, Shosei
    Mizowaki, Takashi
    Kohjimoto, Yasuo
    Hinotsu, Shiro
    Hara, Isao
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1068 - 1079
  • [4] Personalizing the Duration of Androgen-Deprivation Therapy Use in the Management of Intermediate-Risk Prostate Cancer
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (04) : 301 - U151
  • [5] Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
    Uri Amit
    Yaacov R. Lawrence
    Ilana Weiss
    Zvi Symon
    Radiation Oncology, 14
  • [6] Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
    Amit, Uri
    Lawrence, Yaacov R.
    Weiss, Ilana
    Symon, Zvi
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [7] High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer
    Patel, Shyamal
    Demanes, D. Jeffrey
    Ragab, Omar
    Zhang, Mingle
    Veruttipong, Darlene
    Nguyen, Kristine
    Park, Sang-June
    Marks, Leonard
    Pantuck, Allan
    Steinberg, Michael
    Kamrava, Mitchell
    BRACHYTHERAPY, 2017, 16 (02) : 299 - 305
  • [8] Androgen deprivation therapy use and risk of death in men treated with high-dose radiation for intermediate-risk prostate cancer
    Keane, Florence K.
    D'Amico, Anthony V.
    CANCER, 2016, 122 (15) : 2296 - 2298
  • [9] INTERMEDIATE-RISK PROSTATE CANCER, ANDROGEN DEPRIVATION THERAPY AND THE RISK OF DEATH
    Pickles, Tom
    Tyldesley, Scott
    Keyes, Mira
    Morris, W. James
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S27 - S27
  • [10] Intermediate-risk Prostate Cancer Treated with High Dose Radiotherapy Alone or in Combination with Androgen Deprivation Therapy: The Fox Chase Experience
    Sopka, D. M.
    Li, T.
    Horwitz, E. M.
    Chen, D. Y. T.
    Buyyounouski, M. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S351 - S352
12345